Tirzepatide 20MG

Tirzepatide – 20MG

Tirzepatide is a synthetic research peptide studied for its activity as a dual incretin receptor agonist, with research focus on glucose metabolism, metabolic regulation, and body composition models. It is commonly examined in controlled laboratory settings involving GIP and GLP-1 receptor pathway research.

Research Context

Tirzepatide has been investigated in metabolic research due to its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. These pathways are studied for their role in energy balance, insulin signaling, appetite-related signaling, and metabolic response models.

Product Details

• Product: Tirzepatide
• Quantity: 20MG per vial
• Form: Lyophilized powder
• Grade: For research purposes only
• Use: Laboratory research use only

Potential Research Applications

• GIP and GLP-1 receptor pathway studies
• Metabolic regulation and glucose metabolism research
• Insulin signaling and energy balance models
• Body composition and metabolic response investigations
• Comparative incretin-based peptide research

Compliance Statement

This product is supplied strictly for laboratory research use only. It is not intended for human or animal consumption and is not approved for therapeutic, diagnostic, cosmetic, or clinical applications.

Researchers are responsible for ensuring compliance with all applicable local, institutional, and national regulations regarding the handling, storage, and experimental use of this compound.

For research use only. Not for human or animal consumption.